# Gender-Specific Gene Regulation of Ferroptosis in Non-Utilized Liver Donors

**Authors:** Hala Nazzal, Halil Kaan Caliskan, Meghan Unes, Chandrashekhara Manithody, Shun Onishi, Pranjali Rajalakshmi, Yasar Caliskan, Mustafa Nazzal, Ajay Jain

PMC · DOI: 10.3390/genes17020220 · Genes · 2026-02-10

## TL;DR

This study explores how sex influences gene regulation of ferroptosis in non-used donor livers, finding no major sex-based differences in most genes, except for a potential trend in one gene in female livers.

## Contribution

The study is the first to systematically investigate sex-based differences in ferroptosis gene regulation in non-utilized human donor livers using ex vivo normothermic machine perfusion.

## Key findings

- Normothermic machine perfusion of non-utilized donor livers was feasible.
- No significant sex-based differences were found in MDA levels or most ferroptosis-related gene expression after 6 hours.
- ACSF2 expression was higher in female livers, but not significant after multiple testing correction.

## Abstract

Background/Objectives: Females are generally more resistant to ischemia-related ferroptosis than males, due to differences in iron metabolism, antioxidant pathways, and sex hormone-mediated regulation of ferroptosis suppressors. This has not been systematically studied in a human donor liver model. To investigate the effect of sex on ferroptosis and oxidative stress pathways in non-utilized donor livers (NDLs), we assessed patterns of gene expression in NDLs under ex vivo normothermic machine perfusion (NMP). Methods: We utilized the PROTECT dual-circuit ex vivo NMP system to assess three male and two female NDLs undergoing 6 h NMP. Perfusate and tissue samples were collected at baseline and 6 h of NMP. Malondialdehyde (MDA) levels were quantified as biochemical markers of iron overload and lipid peroxidation, respectively. Ferroptosis-related gene expression was assessed using molecular assays. Comparisons between male and female NDLs were used to determine the influence of sex on ferroptosis and oxidative injury during NMP. Results: NMP was successfully performed on NDLs (n = 5) from three male (56.3 ± 5.7 years) and two female donors (46.5 ± 0.7 years, p = 0.15). The fold-change in the oxidative stress marker MDA was comparable between female (1.2 ± 0.6) and male (1.0 ± 0.4) NDLs after 6 h NMP (p = 0.76). All livers showed upregulation of ferroptosis-related genes (Hypoxia-inducible factor 1 alpha, Iron Responsive Binding Elements 2, Ribosomal Protein L8, Ferritin Heavy Chain 1, Acyl-CoA synthetase family member 2, ATP synthase membrane subunit c locus 3, Heme-oxygenase 1, NAD(P)H Quinone Dehydrogenase 1, Tetratricopeptide Repeat Domain 35, Nuclear Factor Erythroid 2 Related Factor 2). ACSF2 expression was significantly higher in female NDLs compared with males undergoing 6 h NMP (3.6 ± 3.0 vs. 1.0 ± 0.7-fold change, p = 0.04). There were no sex-based significant differences observed in the expression of other ferroptosis-related genes (HIF-1α, IREB2, RPL8, FTH-1, ATP5G3, HO-1, NQO1, TTC35, and NRF2) between male and female NDLs. No gene reached statistical significance after false-discovery-rate (FDR) correction. Conclusions: Normothermic machine perfusion of NDLs was feasible, and no sex-related differences were observed in MDA levels or most ferroptosis-related gene expression after 6 h. Although ACSF2 showed higher expression in female livers, this was not significant after multiple testing correction, highlighting the need for larger studies to explore sex-dependent ferroptosis signaling during liver preservation.

## Linked entities

- **Genes:** TED4 (Plant heme oxygenase (decyclizing) family protein) [NCBI Gene 817208], ACSF2 (acyl-CoA synthetase family member 2) [NCBI Gene 80221], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], IREB2 (iron responsive element binding protein 2) [NCBI Gene 3658], RPL8 (ribosomal protein L8) [NCBI Gene 6132], FTH1 (ferritin heavy chain 1) [NCBI Gene 2495], ATP5MC3 (ATP synthase membrane subunit c locus 3) [NCBI Gene 518], HMOX1 (heme oxygenase 1) [NCBI Gene 3162], NQO1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 1728], EMC2 (ER membrane protein complex subunit 2) [NCBI Gene 9694], GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551]
- **Chemicals:** Malondialdehyde (PubChem CID 10964)

## Full-text entities

- **Genes:** TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, NQO1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 1728] {aka DHQU, DIA4, DTD, NMOR1, NMORI, QR1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IREB2 (iron responsive element binding protein 2) [NCBI Gene 3658] {aka ACO3, IRE-BP 2, IRE-BP2, IRP2, IRP2AD, NDCAMA}, FTH1 (ferritin heavy chain 1) [NCBI Gene 2495] {aka FHC, FTH, FTHL6, HFE5, NBIA9, PIG15}, ATL1 (atlastin GTPase 1) [NCBI Gene 51062] {aka AD-FSP, ATL-1, FSP1, HSN1D, SPG3, SPG3A}, AR (androgen receptor) [NCBI Gene 367] {aka AIS, AR8, DHTR, HPCX3, HUMARA, HYSP1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, KCNE4 (potassium voltage-gated channel subfamily E regulatory subunit 4) [NCBI Gene 23704] {aka MIRP3}, PROX1 (prospero homeobox 1) [NCBI Gene 5629], MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, TFRC (transferrin receptor) [NCBI Gene 7037] {aka CD71, IMD46, T9, TFR, TFR1, TR}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, ACSF2 (acyl-CoA synthetase family member 2) [NCBI Gene 80221] {aka ACSMW, AVYV493}, EMC2 (ER membrane protein complex subunit 2) [NCBI Gene 9694] {aka KIAA0103, TTC35}, SULT1E1 (sulfotransferase family 1E member 1) [NCBI Gene 6783] {aka EST, EST-1, ST1E1, STE}, DTL (denticleless E3 ubiquitin protein ligase adapter) [NCBI Gene 51514] {aka CDT2, DCAF2, L2DTL, RAMP}, ATP5MC3 (ATP synthase membrane subunit c locus 3) [NCBI Gene 518] {aka ATP5G3, DYTSPG, P3}, SRY (sex determining region Y) [NCBI Gene 6736] {aka SRXX1, SRXY1, TDF, TDY}, ACSL4 (acyl-CoA synthetase long chain family member 4) [NCBI Gene 2182] {aka ACS4, FACL4, LACS4, MRX63, MRX68, XLID63}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, MBOAT1 (membrane bound glycerophospholipid O-acyltransferase 1) [NCBI Gene 154141] {aka LPEAT1, LPLAT, LPLAT 1, LPLAT14, LPSAT, OACT1}, SLC25A37 (solute carrier family 25 member 37) [NCBI Gene 51312] {aka HT015, MFRN, MFRN1, MSCP}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, RPL8 (ribosomal protein L8) [NCBI Gene 6132] {aka L8, uL2}, MBOAT2 (membrane bound glycerophospholipid O-acyltransferase 2) [NCBI Gene 129642] {aka LPAAT, LPCAT, LPEAT, LPLAT 2, LPLAT13, OACT2}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}
- **Diseases:** iron overload (MESH:D019190), injury to (MESH:D014947), DCD (MESH:D012769), Inflammation (MESH:D007249), COD (MESH:D058494), diabetes mellitus (MESH:D003920), DM (MESH:D009223), obesity (MESH:D009765), macrovesicular steatosis (MESH:D005234), CVA (MESH:D020521), NMP (MESH:D007859), hepatitis C viremia (MESH:D014766), cold ischemia (MESH:D007511), HCV (MESH:D006526), Hepatic Ischemia-Reperfusion Injury (MESH:D015427), hypertension (MESH:D006973), death (MESH:D003643), ischemic injury (MESH:D017202), cardiovascular accident (MESH:D002318), Liver Ferroptosis (MESH:D017093), hepatic (MESH:D056486), necrosis (MESH:D009336)
- **Chemicals:** paraffin (MESH:D010232), Estradiol (MESH:D004958), deferoxamine (MESH:D003676), TRIzol (MESH:C411644), BHT (MESH:D002084), Iron (MESH:D007501), H&amp;E (MESH:D006371), Hematoxylin and Eosin (-), PUFA (MESH:D005231), MDA (MESH:D008315), SYBR  Green (MESH:C098022), Lipid (MESH:D008055), TBARS (MESH:D017392), DFO (MESH:C000709069), ROS (MESH:D017382), formalin (MESH:D005557)
- **Species:** hepatitis C virus [taxon 11103], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940748/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940748/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940748/full.md

---
Source: https://tomesphere.com/paper/PMC12940748